Form 4: Gilead Sciences CFO Andrew Dickinson Reports Stock Transactions
SEC Form 4 Filing
Andrew Dickinson, CFO of Gilead Sciences, reports the vesting and subsequent disposal of restricted stock units.
Summary
- On June 10, 2024, Andrew Dickinson, the Chief Financial Officer of Gilead Sciences, Inc., engaged in transactions involving the company's common stock.
- Dickinson acquired 3,639 shares of common stock through the vesting of restricted stock units.
- Simultaneously, Dickinson disposed of 1,662 shares to cover tax obligations at a price of $65.25 per share.
- Following these transactions, Dickinson directly owns 136,960 shares of Gilead Sciences common stock and 42,768 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, and carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency regarding the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine stock activity by an executive.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of stock transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
| 06/11/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.